Empfehlung
19,9
Stark Verkaufen
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
88.5
61 neu, 107 erhöht, 1017,4M $ netto
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)
Score-Verlauf (90 Tage)
Stammdaten
Unternehmen
| Name | CYTOKINETICS INC |
|---|---|
| Ticker | CYTK |
| CIK | 0001061983 |
Branche
| SIC-Code | 2834 |
|---|---|
| Beschreibung | Pharmaceutical Preparations |
Wertpapier
| CUSIP | 23282Q605 |
|---|---|
| ISIN | US23282Q6055 |
| Typ | Common Stock |
| Titel | CYTOKINETICS INC |
Status
| Zuletzt geprüft | 2026-03-20 22:39:55.21001 |
|---|
Fondsaktivität (letzte 3 Quartale)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 16,395,123 | 15,525,747 | 869,376 | 1,041,746,107 | Aufgestockt | +5,6% | |
| FMR LLC | 36,692,752 | 44,116,647 | -7,423,895 | 847,780,995 | Reduziert | -16,8% | |
| VANGUARD GROUP INC | 12,048,131 | 11,856,795 | 191,336 | 765,538,243 | Aufgestockt | +1,6% | |
| WELLINGTON MANAGEMENT GROUP LLP | 13,027,063 | 22,598,561 | -9,571,498 | 511,603,369 | Reduziert | -42,4% | |
| STATE STREET CORP | 5,825,295 | 5,617,334 | 207,961 | 370,139,244 | Aufgestockt | +3,7% | |
| BANK OF AMERICA CORP /DE/ | 22,380,152 | 23,827,796 | -1,447,644 | 214,532,776 | Reduziert | -6,1% | |
| Deep Track Capital, LP | 3,336,998 | 4,300,000 | -963,002 | 212,032,853 | Reduziert | -22,4% | |
| GEODE CAPITAL MANAGEMENT, LLC | 3,056,017 | 3,040,202 | 15,815 | 194,213,741 | Aufgestockt | +0,5% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2,882,317 | 2,645,301 | 237,016 | 183,142,422 | Aufgestockt | +9,0% | |
| RTW INVESTMENTS, LP | 2,721,158 | 2,721,158 | 0 | 172,902,379 | Unverändert | 0,0% | |
| GOLDMAN SACHS GROUP INC | 6,503,047 | 6,989,723 | -486,676 | 170,324,182 | Reduziert | -7,0% | |
| JPMORGAN CHASE & CO | 2,651,697 | 2,533,757 | 117,940 | 91,774,036 | Aufgestockt | +4,7% | |
| GROUP ONE TRADING LLC | 1,392,053 | 1,668,969 | -276,916 | 88,451,048 | Reduziert | -16,6% | |
| NORTHERN TRUST CORP | 1,380,787 | 1,406,832 | -26,045 | 87,735,208 | Reduziert | -1,9% | |
| MORGAN STANLEY | 5,220,301 | 5,191,186 | 29,115 | 86,023,306 | Aufgestockt | +0,6% | |
| JANE STREET GROUP, LLC | 1,603,125 | 1,134,700 | 468,425 | 75,462,518 | Aufgestockt | +41,3% | |
| LMR Partners LLP | 12,500,000 | 12,500,000 | 0 | 75,414,000 | Unverändert | 0,0% | |
| Capital International Investors | 1,178,780 | 1,178,780 | 0 | 74,899,681 | Unverändert | 0,0% | |
| UBS Group AG | 1,131,456 | 1,823,051 | -691,595 | 71,892,714 | Reduziert | -37,9% | |
| PRINCIPAL FINANCIAL GROUP INC | 976,892 | 1,174,448 | -197,556 | 62,071,717 | Reduziert | -16,8% | |
| Frazier Life Sciences Management, L.P. | 934,642 | 890,445 | 44,197 | 59,387,153 | Aufgestockt | +5,0% | |
| CAPSTONE INVESTMENT ADVISORS, LLC | 13,631,000 | 13,643,094 | -12,094 | 59,098,203 | Reduziert | -0,1% | |
| Fisher Asset Management, LLC | 822,885 | 761,587 | 61,298 | 52,286,113 | Aufgestockt | +8,0% | |
| NORGES BANK | 807,070 | 1,184,072 | -377,002 | 51,281,228 | Reduziert | -31,8% | |
| Pictet Asset Management Holding SA | 757,563 | 1,145,558 | -387,995 | 48,023,193 | Reduziert | -33,9% | |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 747,983 | 1,192,484 | -444,501 | 47,526,840 | Reduziert | -37,3% | |
| BROWN ADVISORY INC | 731,154 | 912,186 | -181,032 | 46,457,519 | Reduziert | -19,8% | |
| Vestal Point Capital, LP | 725,000 | 2,975,000 | -2,250,000 | 39,846,000 | Reduziert | -75,6% | |
| BNP PARIBAS FINANCIAL MARKETS | 579,862 | 247,465 | 332,397 | 36,844,431 | Aufgestockt | +134,3% | |
| ADAR1 Capital Management, LLC | 540,166 | 518,921 | 21,245 | 34,322,148 | Aufgestockt | +4,1% | |
| Qube Research & Technologies Ltd | 537,277 | 9,038 | 528,239 | 34,138,581 | Aufgestockt | +5844,6% | |
| Caption Management, LLC | 523,099 | 334,257 | 188,842 | 33,237,710 | Aufgestockt | +56,5% | |
| BARCLAYS PLC | 604,658 | 409,996 | 194,662 | 32,580,950 | Aufgestockt | +47,5% | |
| Aberdeen Group plc | 483,061 | 927,832 | -444,771 | 30,693,696 | Reduziert | -47,9% | |
| Foresite Capital Management IV, LLC | 458,295 | 458,295 | 0 | 29,120,064 | Unverändert | 0,0% | |
| AQR CAPITAL MANAGEMENT LLC | 513,290 | 0 | 513,290 | 28,210,418 | Neu | +100,0% | |
| AMERICAN CENTURY COMPANIES INC | 443,910 | 429,203 | 14,707 | 28,206,179 | Aufgestockt | +3,4% | |
| ALLIANCEBERNSTEIN L.P. | 412,966 | 235,416 | 177,550 | 26,239,860 | Aufgestockt | +75,4% | |
| FRANKLIN RESOURCES INC | 409,990 | 409,725 | 265 | 26,050,764 | Aufgestockt | +0,1% | |
| DAFNA Capital Management LLC | 370,997 | 394,940 | -23,943 | 23,573,149 | Reduziert | -6,1% | |
| RHUMBLINE ADVISERS | 356,995 | 385,813 | -28,818 | 22,683,428 | Reduziert | -7,5% | |
| ExodusPoint Capital Management, LP | 343,144 | 0 | 343,144 | 21,803,370 | Neu | +100,0% | |
| MARSHALL WACE, LLP | 337,031 | 178,980 | 158,051 | 21,414,949 | Aufgestockt | +88,3% | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 327,202 | 496,673 | -169,471 | 20,790,415 | Reduziert | -34,1% | |
| First Turn Management, LLC | 325,668 | 254,795 | 70,873 | 20,692,945 | Aufgestockt | +27,8% | |
| CITIGROUP INC | 289,501 | 2,844,398 | -2,554,897 | 18,394,893 | Reduziert | -89,8% | |
| Susquehanna Portfolio Strategies, LLC | 278,429 | 278,429 | 0 | 17,691,379 | Unverändert | 0,0% | |
| Catalio Capital Management, LP | 258,381 | 451,581 | -193,200 | 16,417,529 | Reduziert | -42,8% | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 235,049 | 0 | 235,049 | 14,935,014 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 225,456 | 342,533 | -117,077 | 14,325,474 | Reduziert | -34,2% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-18 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -1,930 | 62.07 | -119,795.10 | -33,1% | |
| 2026-03-17 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -4,397 | 62.15 | -273,273.55 | -75,4% | |
| 2026-03-17 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -2,916 | 62.15 | -181,229.40 | -50,0% | |
| 2026-03-17 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -5,626 | 62.15 | -349,655.90 | -96,5% | |
| 2026-03-17 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -7,636 | 62.15 | -474,577.40 | -131,0% | |
| 2026-03-16 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -1,709 | 61.03 | -104,300.27 | -28,8% | |
| 2026-03-16 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -1,709 | 61.03 | -104,300.27 | -28,8% | |
| 2026-03-09 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -2,582 | 60.72 | -156,779.04 | -43,3% | |
| 2026-03-09 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,907 | 60.72 | -176,513.04 | -48,7% | |
| 2026-03-09 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,907 | 60.72 | -176,513.04 | -48,7% | |
| 2026-03-09 | Blum Robert I | Director, Officer, President & CEO | Open Market Sale | -7,931 | 60.72 | -481,570.32 | -132,9% | |
| 2026-03-09 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -2,582 | 60.72 | -156,779.04 | -43,3% | |
| 2026-03-05 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -11,000 | 61.88 | -680,680.00 | -187,9% | |
| 2026-03-05 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -15,000 | 61.87 | -928,050.00 | -256,1% | |
| 2026-03-05 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -15,000 | 61.87 | -928,050.00 | -256,1% | |
| 2026-03-05 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -11,000 | 61.88 | -680,680.00 | -187,9% | |
| 2026-03-02 | PARSHALL B LYNNE | Director | Open Market Sale | -5,000 | 61.21 | -306,050.00 | -84,5% | |
| 2026-03-02 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -886 | 61.62 | -54,595.32 | -15,1% | |
| 2026-03-02 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -886 | 61.62 | -54,595.32 | -15,1% | |
| 2026-02-05 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -15,000 | 61.93 | -928,950.00 | -256,4% | |
| 2026-02-05 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -15,000 | 61.93 | -928,950.00 | -256,4% | |
| 2026-02-02 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -886 | 62.10 | -55,020.60 | -15,2% | |
| 2026-02-02 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -886 | 62.10 | -55,020.60 | -15,2% | |
| 2026-01-05 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -15,000 | 60.28 | -904,200.00 | -249,5% | |
| 2026-01-05 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -15,000 | 60.28 | -904,200.00 | -249,5% | |
| 2026-01-02 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -913 | 62.09 | -56,688.17 | -15,6% | |
| 2026-01-02 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -885 | 63.16 | -55,896.60 | -15,4% | |
| 2026-01-02 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -913 | 62.09 | -56,688.17 | -15,6% | |
| 2026-01-02 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -885 | 63.16 | -55,896.60 | -15,4% | |
| 2025-12-29 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -1,809 | 62.44 | -112,953.96 | -31,2% | |
| 2025-12-29 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -1,809 | 62.44 | -112,953.96 | -31,2% | |
| 2025-12-22 | WIERENGA WENDELL | Director | Open Market Sale | -20,000 | 66.14 | -1,322,800.00 | -365,1% | |
| 2025-12-16 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,200 | 61.24 | -134,728.00 | -37,2% | |
| 2025-12-16 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,200 | 61.24 | -134,728.00 | -37,2% | |
| 2025-12-08 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -1,042 | 65.96 | -68,730.32 | -19,0% | |
| 2025-12-08 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -1,042 | 65.96 | -68,730.32 | -19,0% | |
| 2025-12-05 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -52,486 | 65.95 | -3,461,451.70 | -955,3% | |
| 2025-12-05 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -52,486 | 65.95 | -3,461,451.70 | -955,3% | |
| 2025-12-02 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,200 | 63.89 | -140,558.00 | -38,8% | |
| 2025-12-02 | HENDERSON JOHN T | Director | Open Market Sale | -8,750 | 63.90 | -559,125.00 | -154,3% | |
| 2025-12-02 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,200 | 63.89 | -140,558.00 | -38,8% | |
| 2025-12-01 | Kaye Edward M. MD | Director | Open Market Sale | -28,064 | 66.72 | -1,872,430.08 | -516,8% | |
| 2025-12-01 | Harrington Robert Arthur | Director | Open Market Sale | -2,150 | 66.80 | -143,620.00 | -39,6% | |
| 2025-11-19 | PARSHALL B LYNNE | Director | Open Market Sale | -5,000 | 64.73 | -323,650.00 | -89,3% | |
| 2025-11-18 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,200 | 66.45 | -146,190.00 | -40,3% | |
| 2025-11-18 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,200 | 66.45 | -146,190.00 | -40,3% | |
| 2025-11-11 | Kaye Edward M. MD | Director | Open Market Sale | -5,175 | 65.08 | -336,789.00 | -92,9% | |
| 2025-11-04 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,295 | 59.55 | -136,667.25 | -37,7% | |
| 2025-11-04 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,295 | 59.55 | -136,667.25 | -37,7% | |
| 2025-10-30 | Blum Robert I | Director, Officer, President & CEO | Open Market Sale | -5,000 | 62.86 | -314,300.00 | -86,7% | |
| 2025-10-27 | WIERENGA WENDELL | Director | Open Market Sale | -4,375 | 58.68 | -256,725.00 | -70,9% | |
| 2025-10-21 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,105 | 58.22 | -122,553.10 | -33,8% | |
| 2025-10-21 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,105 | 58.22 | -122,553.10 | -33,8% | |
| 2025-10-16 | Blum Robert I | Director, Officer, President & CEO | Open Market Sale | -5,000 | 60.03 | -300,150.00 | -82,8% | |
| 2025-10-07 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,000 | 60.56 | -121,120.00 | -33,4% | |
| 2025-10-07 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,000 | 60.56 | -121,120.00 | -33,4% | |
| 2025-10-06 | Kaye Edward M. MD | Director | Open Market Sale | -6,757 | 60.00 | -405,420.00 | -111,9% | |
| 2025-10-01 | Blum Robert I | Director, Officer, President & CEO | Open Market Sale | -5,000 | 55.05 | -275,250.00 | -76,0% | |
| 2025-09-30 | Kaye Edward M. MD | Director | Open Market Sale | -6,695 | 55.08 | -368,760.60 | -101,8% | |
| 2025-09-23 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,000 | 49.28 | -98,560.00 | -27,2% | |
| 2025-09-23 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,000 | 49.28 | -98,560.00 | -27,2% | |
| 2025-09-15 | Blum Robert I | Director, Officer, President & CEO | Open Market Sale | -5,000 | 49.77 | -248,850.00 | -68,7% | |
| 2025-09-09 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,000 | 51.29 | -102,580.00 | -28,3% | |
| 2025-08-19 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,000 | 38.31 | -76,620.00 | -21,1% | |
| 2025-08-05 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,000 | 36.34 | -72,680.00 | -20,1% | |
| 2025-07-22 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,000 | 37.47 | -74,940.00 | -20,7% | |
| 2025-07-08 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,000 | 33.76 | -67,520.00 | -18,6% | |
| 2025-06-17 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,000 | 32.91 | -65,820.00 | -18,2% | |
| 2025-06-05 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -8,659 | 32.04 | -277,434.36 | -76,6% | |
| 2025-06-03 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,000 | 31.88 | -63,760.00 | -17,6% | |
| 2025-05-20 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,000 | 31.98 | -63,960.00 | -17,7% | |
| 2025-05-06 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,000 | 35.01 | -70,020.00 | -19,3% | |
| 2025-05-05 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -4,002 | 36.68 | -146,793.36 | -40,5% | |
| 2025-04-22 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,000 | 38.11 | -76,220.00 | -21,0% | |
| 2025-04-08 | Malik Fady Ibraham | Officer, EVP Research & Development | Open Market Sale | -2,000 | 36.18 | -72,360.00 | -20,0% | |
| 2025-04-07 | Callos Andrew | Officer, EVP, Chief Commercial Officer | Open Market Sale | -2,886 | 35.78 | -103,261.08 | -28,5% |
Top-Fondshalter (aktuelles Quartal)
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| BlackRock, Inc. | 16,395,123 | 1,041,746,107 | 15.46 |
| FMR LLC | 36,692,752 | 847,780,995 | 12.59 |
| VANGUARD GROUP INC | 12,048,131 | 765,538,243 | 11.36 |
| WELLINGTON MANAGEMENT GROUP LLP | 13,027,063 | 511,603,369 | 7.59 |
| STATE STREET CORP | 5,825,295 | 370,139,244 | 5.49 |
| BANK OF AMERICA CORP /DE/ | 22,380,152 | 214,532,776 | 3.18 |
| Deep Track Capital, LP | 3,336,998 | 212,032,853 | 3.15 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,056,017 | 194,213,741 | 2.88 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2,882,317 | 183,142,422 | 2.72 |
| RTW INVESTMENTS, LP | 2,721,158 | 172,902,379 | 2.57 |
| GOLDMAN SACHS GROUP INC | 6,503,047 | 170,324,182 | 2.53 |
| JPMORGAN CHASE & CO | 2,651,697 | 91,774,036 | 1.36 |
| GROUP ONE TRADING LLC | 1,392,053 | 88,451,048 | 1.31 |
| NORTHERN TRUST CORP | 1,380,787 | 87,735,208 | 1.30 |
| MORGAN STANLEY | 5,220,301 | 86,023,306 | 1.28 |
| JANE STREET GROUP, LLC | 1,603,125 | 75,462,518 | 1.12 |
| LMR Partners LLP | 12,500,000 | 75,414,000 | 1.12 |
| Capital International Investors | 1,178,780 | 74,899,681 | 1.11 |
| UBS Group AG | 1,131,456 | 71,892,714 | 1.07 |
| PRINCIPAL FINANCIAL GROUP INC | 976,892 | 62,071,717 | 0.92 |